International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 3 major types of innate and adaptive cell-mediated effector immunity
Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.001 · Cited by 818
Enhanced innate type 2 immune response in peripheral blood from patients with asthma
Bartemes, K. R., Kephart, G. M., Fox, S. J., & Kita, H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.024 · Cited by 390 · cited 1×
“Circulating ILC2 responses are increased in asthmatic patients but not in those with allergic rhinitis.(38) For further information, see Box 1 and Fig 2.”
BackgroundLao-Araya, M., Steveling, E., Scadding, G. W., Durham, S. R., & Shamji, M. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.029 · Cited by 200 · cited 1×
“AIT has been shown to regulate ILCs, and seasonal increases in peripheral ILC2 numbers are inhibited by subcutaneous grass pollen immunotherapy.(37) Circulating ILC2 responses are increased in asthmatic patients but not in those with allergic rhinitis.”
BackgroundNolte, H., Maloney, J., Nelson, H. S., Bernstein, D. I., Lu, S., Li, Z., Kaur, A., Zieglmayer, P., Zieglmayer, R., Lemell, P., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1911 · Cited by 160 · cited 2×
“BARRIERS AND FACILITATORS FOR AIT In spite of the facts that AIT represents a well-established, evidence-based therapy and that there has been great progress in both vaccine development and means of application in recent years, a number of key barriers and facilitators should be noted, as shown in Table II.(70,71)”
MethodSelf-citationSuárez-Fueyo, A., Ramos, T., Galán, A., Jimeno, L., Wurtzen, P. A., Marin, A., de Frutos, C., Blanco, C., Carrera, A. C., Barber, D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.043 · Cited by 147 · cited 1×
“A significant correlation exists between improvement of symptoms and the increase in inducible Treg cell numbers during immunotherapy.(14,15) Inducible Treg cells are composed of 2 sets: forkhead box protein 3 (FOXP3)–adaptive Treg cells and FOXP3(2) but IL-10–producing type 1 regulatory cells.”
BackgroundThe Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
Agache, I., Sugita, K., Morita, H., Akdis, M., & Akdis, C. A. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0529-x · Cited by 86
Self-citationRösner-Friese, K., Kaul, S., Vieths, S., & Pfaar, O. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.045 · Cited by 66 · cited 2×
“BARRIERS AND FACILITATORS FOR AIT In spite of the facts that AIT represents a well-established, evidence-based therapy and that there has been great progress in both vaccine development and means of application in recent years, a number of key barriers and facilitators should be noted, as shown in Table II.(70,71)”
MethodSelf-citationImmunologic characterization of 3 murine regimens of allergen-specific immunotherapy
Fox, E. M., Torrero, M. N., Evans, H., & Mitre, E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.052 · Cited by 15
Cited by
EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis
Roberts, G., Pfaar, O., Akdis, C. A., Ansotegui, I. J., Durham, S. R., Gerth van Wijk, R., Halken, S., Larenas‐Linnemann, D., Pawankar, R., Pitsios, C., et al. (2018) · Allergy · doi:10.1111/all.13317 · Cited by 702
Self-citationInternational Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationAirborne bioaerosols and their impact on human health
Kim, K.-H., Kabir, E., & Jahan, S. A. (2018) · Journal of Environmental Sciences · doi:10.1016/j.jes.2017.08.027 · Cited by 543
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationMechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Palomares, O., Akdis, M., Martín‐Fontecha, M., & Akdis, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 330
Self-citationAkdis (2020) · doi:10.1111/pai.13189 · Cited by 320
EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma
Agache, I., Lau, S., Akdis, C. A., Smolinska, S., Bonini, M., Cavkaytar, O., Flood, B., Gajdanowicz, P., Izuhara, K., Kalayci, O., et al. (2019) · Allergy · doi:10.1111/all.13749 · Cited by 319
Self-citationSampson, H. A., O'Mahony, L., Burks, A. W., Plaut, M., Lack, G., & Akdis, C. A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.11.005 · Cited by 298
Self-citationMuraro, A., Lemanske, R. F., Hellings, P. W., Akdis, C. A., Bieber, T., Casale, T. B., Jutel, M., Ong, P. Y., Poulsen, L. K., Schmid-Grendelmeier, P., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.010 · Cited by 284
Self-citationRole of regulatory B cells in immune tolerance to allergens and beyond
van de Veen, W., Stanic, B., Wirz, O. F., Jansen, K., Globinska, A., & Akdis, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.006 · Cited by 258
Self-citationA WAO—ARIA—GA2LEN Consensus Document on Molecular-Based Allergy Diagnosis (PAMD@): Update 2020
Ansotegui, I. J., Melioli, G., Canonica, G. W., Gómez, R. M., Jensen-Jarolim, E., Ebisawa, M., Luengo, O., Caraballo, L., Passalacqua, G., Poulsen, L. K., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100091 · Cited by 122
Self-citationMechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
Sahiner, U. M., Giovannini, M., Escribese, M. M., Paoletti, G., Heffler, E., Alvaro Lozano, M., Barber, D., Canonica, G. W., & Pfaar, O. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050845 · Cited by 66
Self-citationImmunotherapy in allergic rhinitis and lower airway outcomes
Cardona, V., Luengo, O., & Labrador-Horrillo, M. (2017) · Allergy · doi:10.1111/all.12989 · Cited by 50
Pharmacological Management of Allergic Rhinitis in the Elderly
Bozek, A. (2017) · Drugs & Aging · doi:10.1007/s40266-016-0425-7 · Cited by 48
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
Larsson, O., Hellkvist, L., Peterson-Westin, U., & Cardell, L. O. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1190829 · Cited by 16
Metadata
- Authors
- Jutel, M., Agache, I., Bonini, S., Burks, A. W., Calderon, M., Canonica, W., Cox, L., Demoly, P., Frew, A. J., O'Hehir, R., Kleine-Tebbe, J., Muraro, A., Lack, G., Larenas, D., Levin, M., Martin, B. L., Nelson, H., Pawankar, R., Pfaar, O., van Ree, R., Sampson, H., Sublett, J. L., Sugita, K., Du Toit, G., Werfel, T., Gerth van Wijk, R., Zhang, L., Akdis, M., & Akdis, C. A.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 137
- Issue
- 2
- Pages
- 358-368
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2272379762
- Cited by
- 244
- References
- 8
- FWCI
- 30.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.